Source: The Investor

Yozma Group: SCM Lifescience secures W2b from Yozma

Korea’s biotech firm SCM Lifescience said on Sept. 11 it has attracted 2 billion won (US$1.78 million) from the Yozma Group, an Israeli venture capital firm

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100